Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

Sima Jeha; H. Kantarjian; David Irwin; Violet Shen; S. Shenoy; Susan M. Blaney; Bruce M. Camitta; C‐H Pui

doi:10.1038/sj.leu.2403566

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

Sima Jeha(St. Jude Children's Research Hospital), H. Kantarjian(The University of Texas MD Anderson Cancer Center), David Irwin(Alta Bates Summit Medical Center), Violet Shen(Children's Hospital of Orange County), S. Shenoy(Washington University in St. Louis), Susan M. Blaney(Children's Cancer Center), Bruce M. Camitta(Medical College of Wisconsin), C‐H Pui(St. Jude Children's Research Hospital)

Leukemia

October 28, 2004

10.1038/sj.leu.2403566

Cited by 180

Abstract

Related Papers

No related papers found

Powered by citation graph analysis